The relation between health insurance and management of hypertension in Shanghai, China: A cross-sectional study

BMC Public Health

Volumn 16, Issue 1, 2016, Pages

  Zhang, Xinji ^a   Zhang, Yuan ^a   Xiao, Xiang ^a   Ma, Xiuqiang ^a   He, Jia ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Disease management; Health insurance; Hypertension

Indexed keywords

ADOLESCENT; ADULT; AGED; BLOOD PRESSURE; CHINA; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FEMALE; HEALTH INSURANCE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD PRESSURE; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; INSURANCE, HEALTH; MALE; MIDDLE AGED; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84986918064     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-016-3627-3     Document Type: Article

References (23)

1. World Health Organization. World health report 2002: reducing risks, promoting healthy life. World Health Organ Geneva Switz. 2002;16(2):230.
2. Gu H, Li W, Yang J, Wang Y, Bo J, Liu L. Hypertension prevalence, awareness, treatment and control among Han and four ethnic minorities (Uygur, Hui, Mongolian and Dai) in China. J Hum Hypertens. 2015;29(9):555-60.
3. Wang W, Hu SS, Kong LZ, Gao RL, Zhu ML, Wang WY, Wu ZS, Chen WW, Yang JG, Ma LY, Liu MB. Summary of report on cardiovascular diseases in China, 2012. Biomed Environ Sci. 2014;27(7):552-8.
4. Jacques A, Bernard C, Nathalie G, Christelle C, Michel S, Jean Pierre C. Why is hypertension so frequently uncontrolled in secondary prevention? J Hypertens. 2003;21(6):1199-205.
5. Ovbiagele B, Goldstein LB, Higashida RT, Howard VJ, Johnston SC, Khavjou OA, Lackland DT, Lichtman JH, Mohl S, Sacco RL, et al. Forecasting the Future of Stroke in the United States A Policy Statement From the American Heart Association and American Stroke Association. Stroke. 2013;44(8):2361-75.
6. Li S, Bruen BK, Lantz PM, Mendez D. Impact of Health Insurance Expansions on Nonelderly Adults With Hypertension. Prev Chronic Dis. 2015;12:E105.
7. Gillespie C, Kuklina EV, Briss PA, Blair NA, Hong Y. Vital Signs: Prevalence, Treatment, and Control of Hypertension-United States, 1999-2002 and 2005-2008 (Reprinted from MMWR, vol 60, pg 103-108, 2011). JAMA. 2011;305(15):1531.
8. Meng QY, Fang H, Liu XY, Yuan BB, Xu J. Consolidating the social health insurance schemes in China: towards an equitable and efficient health system. Lancet. 2015;386(10002):1484-92.
9. Liu J, Shi L, Meng Q, Khan MM. Income-related inequality in health insurance coverage: analysis of China Health and Nutrition Survey of 2006 and 2009. Int J Equity Health. 2012;11(18):1-11.
10. Li Y, Rao K, Ren X. Use of and factors associated with self-treatment in China. BMC Public Health. 2012;12(1):1-9.
11. Xu Y, Gao J, Zhou Z, Xue Q, Yang J, Luo H, Li Y, Lai S, Chen G. Measurement and explanation of socioeconomic inequality in catastrophic health care expenditure: evidence from the rural areas of Shaanxi Province. BMC Health Serv Res. 2015;15:256.
12. Bello Y. Error Detection in Outpatients' Age Data Using Demographic Techniques. Int J Pure Appl Sci Technol. 2012;10:27-36.
13. Gu J, Zhang XJ, Wang TH, Zhang Y, Chen Q. Hypertension knowledge, awareness, and self-management behaviors affect hypertension control: a community-based study in Xuhui District, Shanghai, China. Cardiology. 2014;127(2):96-104.
14. Park JM, Kang K, Cho YJ, Hong KS, Lee KB, Park TH, Lee SJ, Ko Y, Han MK, Lee J. Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome. Ann Neurol. 2016;79:560-8.
15. Mccaffrey DF, Griffin BA, Almirall D, Slaughter ME, Ramchand R, Burgette LF. A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med. 2013;32(19):3388-414.
16. He J. Hypertension in China: a large and increasing public health challenge. J Hypertens. 2016;34(1):29-31.
17. Feng XL, Pang M, Beard J. Health system strengthening and hypertension awareness, treatment and control: data from the China Health and Retirement Longitudinal Study. Bull World Health Organ. 2014;92(1):29-41.
18. Li H, Wei X, Wong MC, Yang N, Wong SY, Lao X, Griffiths SM. A comparison of the quality of hypertension management in primary care between Shanghai and Shenzhen: a cohort study of 3196 patients. Medicine. 2015;94(5):e455.
19. Li YC, Wang LM, Jiang Y, Li XY, Zhang M, Hu N. Prevalence of hypertension among Chinese adults in 2010. Zhonghua Yu Fang Yi Xue Za Zhi [Chinese journal of preventive medicine]. 2010;46(5):409-13.
20. Xu Y, Bi Y, Li M, Wang W, Wang T, Wang L, Jiang Y, Xu M, Lu J, Li J, et al. Prevalence, Awareness, Treatment, and Control of Hypertension in China: The China Metabolic Risk Factor Study. Circulation. 2013;127(12):A005.
21. Carter BL. Implementing the new guidelines for hypertension: JNC 7, ADA, WHO-ISH. J Manag Care Pharm. 2004;10(5 Suppl A):S18-25.
22. Fu R, Wang Y, Bao H, Wang Z, Li Y, Su S, Liu M. Trend of Urban-rural Disparities in Hospital Admissions and Medical Expenditure in China from 2003 to 2011. PLoS One. 2014;9(9):e108571.108571-7.
23. Meng N, Qiang Z, Min Y. Comparison of self-reported and biomedical data on hypertension and diabetes: findings from the China Health and Retirement Longitudinal Study (CHARLS). BMJ Open. 2016;6(1):e009836.